Ebstein-Barr virus antibodies titer before and after radiotherapy in patients with nasopharyngeal carcinoma, Cancer Institute, Imam Khomeini Hospital, 2003 – 2004

F. Amoozegar Hashemi,; F.Razi,; E.Esmati,; M.Sajjadi,

Volume 64, Issue 5 (1 2006) Tehran Univ Med J 2006, 64(5): 96-101 | Back to browse issues page

Mendeley

Zotero

RefWorks

F. Amoozegar Hashemi, F.Razi, E.Esmati, M.Sajjadi. Ebstein-Barr virus antibodies titer before and after radiotherapy in patients with nasopharyngeal carcinoma, Cancer Institute, Imam Khomeini Hospital, 2003 – 2004. Tehran Univ Med J 2006; 64 (5) :96-101
URL: http://tumj.tums.ac.ir/article-1-953-en.html

Ebstein-Barr virus antibodies titer before and after radiotherapy in patients with nasopharyngeal carcinoma, Cancer Institute, Imam Khomeini Hospital, 2003 – 2004

F. Amoozegar Hashemi ^*

, F.Razi

, E.Esmati

, M.Sajjadi

Abstract: (5762 Views)

Background: High titer of IgA and IgG are found in the presence of EBV genome in epithelial cells of nasopharyngeal carcinoma. In this survey we evaluated the accuracy of EBV antibodies titers in screening and follow up the patients.

Methods: Thirty nasopharyngeal carcinoma patients were followed from 2003 to 2004. Serum EBV antibody levels were measured before and after ( 3 months ) radiotherapy or combined radiotherapy and chemotherapy.

Results: More than 77% of patients were seropositive before treatment .The antibodies decreased significantly, 3 months after treatment (p<0.05).

Conclusion: This investigation shows the efficiency of serologic methods for screening of high risk people and follow up of patients after treatment, but more complementary studies is needed

Keywords: nasopharyngeal carcinoma

Full-Text [PDF 122 kb] (2787 Downloads)